Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tenaya Therapeutics ( (TNYA) ) has issued an update.
Tenaya Therapeutics, Inc. has undergone board restructuring with Karah Parschauer transitioning from a Class I to a Class II director to better balance the board’s composition, without any changes to her compensation or service continuity. Additionally, the company adopted a new 2024 Inducement Equity Incentive Plan, reserving 1.2 million shares for new equity awards aimed at attracting new talent and potentially facilitating mergers or acquisitions, in compliance with Nasdaq’s inducement award rules.
Learn more about TNYA stock on TipRanks’ Stock Analysis page.